Dirk G. Brockstedt - 13 Nov 2024 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Signature
/s/ Rodney Young, Attorney-in-Fact
Issuer symbol
RAPT
Transactions as of
13 Nov 2024
Transactions value $
$0
Form type
4
Filing time
15 Nov 2024, 20:00:13
Previous filing
01 Feb 2024
Next filing
03 Feb 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPT Employee Stock Option (right to buy) Disposed to Issuer $0 -20K -100% $0.00 0 13 Nov 2024 Common Stock 20K $44.66 Direct F1
transaction RAPT Employee Stock Option (right to buy) Award $0 +20K $0.00 20K 13 Nov 2024 Common Stock 20K $1.57 Direct F1
transaction RAPT Employee Stock Option (right to buy) Disposed to Issuer $0 -50K -100% $0.00 0 13 Nov 2024 Common Stock 50K $19.53 Direct F2, F3
transaction RAPT Employee Stock Option (right to buy) Award $0 +50K $0.00 50K 13 Nov 2024 Common Stock 50K $1.57 Direct F2, F3
transaction RAPT Employee Stock Option (right to buy) Disposed to Issuer $0 -55K -100% $0.00 0 13 Nov 2024 Common Stock 55K $19.86 Direct F4, F5
transaction RAPT Employee Stock Option (right to buy) Award $0 +55K $0.00 55K 13 Nov 2024 Common Stock 55K $1.57 Direct F4, F5
transaction RAPT Employee Stock Option (right to buy) Disposed to Issuer $0 -56K -100% $0.00 0 13 Nov 2024 Common Stock 56K $29.05 Direct F6, F7
transaction RAPT Employee Stock Option (right to buy) Award $0 +56K $0.00 56K 13 Nov 2024 Common Stock 56K $1.57 Direct F6, F7
transaction RAPT Employee Stock Option (right to buy) Disposed to Issuer $0 -75K -100% $0.00 0 13 Nov 2024 Common Stock 75K $24.75 Direct F8, F9
transaction RAPT Employee Stock Option (right to buy) Award $0 +75K $0.00 75K 13 Nov 2024 Common Stock 75K $1.57 Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 30, 2020 and is fully vested.
F2 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 28, 2021.
F3 1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting start date of January 1, 2021.
F4 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 28, 2022.
F5 1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting commencement date of January 1, 2022.
F6 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 31, 2023.
F7 1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting commencement date of January 1, 2023.
F8 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 1, 2024.
F9 1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting commencement date of January 1, 2024.